Contribution: Industrial Research Assistance Program – Contributions to Firms
ARTMS Inc.
$591,000.00
E!17003 Ga68-PSMA-11 - Ga-68 Cyclotron Production for Prostate Specific Membrane Antigen (PSMA) Radiopharmaceutical Use in Prostate Cancer
FY 2021-22 · 2021-10-01
Summary
EUREKA E!17003 Ga-68-PSMA-11 project with an Israeli partner Isotopia Molecular Imaging Ltd to develop high activity gallium-68 (Ga-68) cyclotron production for Prostate Specific Membrane Antigen (PSMA) radiopharmaceutical use and treatment monitoring in patients with prostate cancer.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Burnaby|Burnaby, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
838054435
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-10-01 | 2021-22 | $591,000.00 |
| 1 | 2021-10-01 | 2021-22 | $591,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 92 jours.
Agreement End Date
2022-12-31
Agreement Number
981998
Agreement Start Date
2021-10-01
Agreement Title
E!17003 Ga68-PSMA-11 - Ga-68 Cyclotron Production for Prostate Specific Membrane Antigen (PSMA) Radiopharmaceutical Use in Prostate Cancer
Agreement Title (French)
E!17003 Ga68-PSMA-11 - Production de cyclotron de Ga-68 pour l'utilisation radiopharmaceutique de l'antigène membranaire propre à la prostate dans le cancer de la prostate
Agreement Type
Contribution
Agreement Value
$591,000.00
Amendment Date
2022-08-29
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
EUREKA E!17003 Ga-68-PSMA-11 project with an Israeli partner Isotopia Molecular Imaging Ltd to develop high activity gallium-68 (Ga-68) cyclotron production for Prostate Specific Membrane Antigen (PSMA) radiopharmaceutical use and treatment monitoring in patients with prostate cancer.
Description (French)
Projet EUREKA E!17003 Ga-68-PSMA-11 avec un partenaire israélien, Isotopia Molecular Imaging Ltd, pour développer la production de cyclotron de gallium-68 (Ga-68) cyclotron de haute activité pour l'utilisation radiopharmaceutique de l'antigène membranaire propre à la prostate et le suivi du traitement chez les patients atteints de cancer de la prostate.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
838054435
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
ARTMS Inc.
Recipient Operating Name
ARTMS
Recipient Postal Code
V5A 4N5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-981998
